COMPANY PROFILE

Anagenex

Explore full profile

Biotechnology company building a novel platform for drug discovery focusing on difficult targets

San Francisco, United StatesFounded 2019Biotech & Life Sciences

Valuation $100–250M Last recorded · 2022

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Anagenex

Anagenex is a biotechnology company focused on accelerating the drug discovery process by leveraging advanced machine learning and extensive biochemical datasets. Operating in the pharmaceutical and healthcare markets, Anagenex serves clients ranging from large pharmaceutical companies to research institutions. The company’s business model revolves around identifying and testing billions of custom synthesized compounds to find potential medicines that can modulate disease-causing proteins. By integrating expertise in biology, chemistry, and machine learning, Anagenex aims to reduce the time it takes to bring new medicines to market, thereby addressing unmet medical needs more efficiently. Revenue is generated through partnerships, licensing agreements, and potentially through the commercialization of discovered compounds.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2019
Headquarters: San Francisco, United States
Employees: 5
Open positions: None listed
Dealroom signal: 61.5/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology, Health Platform
Sector: Biotech & Life Sciences, Biotechnology, Drug Development, DNA, Genetics and genomics, Biotech and Pharma, Hard Tech, proteomics, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Jun 2022	$30M	$120M	Obvious Ventures · Khosla Ventures · Lux Capital · Menlo Ventures	↗
SEEDEquity / VC	Jan 2022	$7.2M	$29M	Menlo Ventures · Lux Capital · Obvious Ventures · Khosla Ventures	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Anagenex website traffic

Latest recorded traffic for Anagenex is 40K monthly website visits, up 11.1% over the last three months. Anagenex's team declined 16.7% over the past year.

Latest monthly visits40K 3-month web change+11.1% 1-year team growth-16.7%

Monthly website visitsJun 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OPOppilotechComputational biology platform for first-in-class drug discovery	London, United Kingdom	Operational	10	$384K	—
EMEmpiricoHuge biological datasets, human genetics, and programmable biology to power novel target discovery and development	San Diego, United States	Operational
OBOnramp BioInformaticsOur software, services and systems empower biotech companies, researchers & doctors to unlock genomic data insights	San Diego, United States	Operational
PTProQR TherapeuticsDevelops RNA therapies to potentially transform the lives of patients suffering from genetic rare diseases	Leiden, Netherlands	Operational
CDC4X DiscoveryC4X Discovery - building the world's most productive drug discovery engine	Manchester, United Kingdom	Operational
NTNimbus TherapeuticsApplying deep computational chemistry expertise to create novel small molecule therapeutics	Cambridge, United States	Acquired
SCScancellClinical-stage immunotherapies for difficult-to-treat cancers	Oxford, United Kingdom	Operational
IBInVivo BiosystemsAccelerating deep in-vivo insights into human biology and enable researchers to develop and deliver solutions that improve human health	Eugene, United States	Operational